Form 8-K - Current report:
SEC Accession No. 0001171843-25-001050
Filing Date
2025-02-25
Accepted
2025-02-25 08:00:49
Documents
15
Period of Report
2025-02-17
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_022425.htm   iXBRL 8-K 43865
2 EXHIBIT 10.4 exh_104.htm EX-10.4 14569
3 EXHIBIT 99.1 exh_991.htm EX-99.1 149674
  Complete submission text file 0001171843-25-001050.txt   404102

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bysi-20250217.xsd EX-101.SCH 3045
5 XBRL LABEL FILE bysi-20250217_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE bysi-20250217_pre.xml EX-101.PRE 24185
18 EXTRACTED XBRL INSTANCE DOCUMENT f8k_022425_htm.xml XML 3687
Mailing Address 100 CAMPUS DRIVE, WEST SIDE, 4TH FLOOR SUITE 410 FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE, WEST SIDE, 4TH FLOOR SUITE 410 FLORHAM PARK NJ 07932 646-528-4184
BeyondSpring Inc. (Filer) CIK: 0001677940 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38024 | Film No.: 25659474
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)